Baseline characteristics of patients at high risk of hyperkalaemia who did or did not develop hyperkalaemia (K+ >5.0 mEq/L) during mineralocorticoid receptor antagonist titration. This evidence concerns the gene NR3C2 and Hyperkalemia.